Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization

Journal of Neuroscience

Volumn 29, Issue 4, 2009, Pages 987-997

  Lanteri, Christophe ^a,b   Vallejo, Sandra Jimena Hernández ^b,c   Salomon, Lucas ^a,b   Doucet, Emilie Lucie ^a,b   Godeheu, Gérard ^a   Torrens, Yvette ^a   Houades, Vanessa ^a   Tassin, Jean Pol ^a  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSERM   (France)

Author keywords

1b adrenergic receptor; 5 HT1A receptor; 5 HT2A serotonergic receptor; Microdialysis; Nicotine; Tranylcypromine

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING); AMPHETAMINE; COCAINE; EPLIVANSERIN; MORPHINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINE; PRAZOSIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A ANTAGONIST; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; ENZYME INHIBITION; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NEUROCHEMISTRY; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; SENSITIZATION; SEROTONINERGIC NERVE CELL; TOBACCO DEPENDENCE;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORECEPTORS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DRUG COMBINATIONS; FLUOROBENZENES; MALE; MICE; MICE, INBRED C57BL; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NICOTINE; NICOTINIC AGONISTS; PHENOLS; PIPERAZINES; PRAZOSIN; PYRIDINES; RAPHE NUCLEI; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TRANYLCYPROMINE;

EID: 59649115413     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3315-08.2009     Document Type: Article

References (63)

1. Auclair A, Cotecchia S, Glowinski J, Tassin JP (2002) D-Amphetamine fails to increase extracellular dopamine levels in mice lacking α1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J Neurosci 22:9150-9154.
2. 2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073-3084.
3. Balfour DJ, Benwell ME, Birrell CE, Kelly RJ, Al-Aloul M (1998) Sensitization of the mesoaccumbens dopamine response to nicotine. Pharmacol Biochem Behav 59:1021-1030.
4. Baraban JM, Aghajanian GK (1980) Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19:355-363.
5. Berlin I, Said S, Spreux-Varoquaux O, Olivares R, Launay JM, Puech AJ (1995) Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 38:756-761.
6. Blanc G, Trovero F, Vezina P, Hervé D, Godeheu AM, Glowinski J, Tassin JP (1994) Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6:293-298.
7. Bortolozzi A, Artigas F (2003) Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha1-adrenoceptors. Neuropsychopharmacology 28:421-434.
8. Brazell MP, Mitchell SN, Gray JA (1991) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology 30:823-833.
9. Breyer-Pfaff U, Wiatr G, Stevens I, Gaertner HJ, Mundle G, Mann K (1996) Elevated norharman plasma levels in alcoholic patients and controls resulting from tobacco smoking. Life Sci 58:1425-1432.
10. Carey RJ, Depalma G, Damianopoulos E, Müller CP, Huston JP (2004) The 5-HT1A receptor and behavioral stimulation in the rat: effects of 8-OHDPATon spontaneous and cocaine-induced behavior. Psychopharmacology (Berl) 177:46-54.
11. 3H]-dopamine release. Br J Pharmacol 117:595-606.
12. Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905-908.
13. Darracq L, Blanc G, Glowinski J, Tassin JP (1998) Importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18:2729-2739.
14. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393:295-314.
15. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274-5278.
16. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, Tassin JP (2002) α1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22:2873-2884.
17. Egan TM, North RA (1986) Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro. Neuroscience 19:565-571.
18. el Mestikawy S, Riad M, Laporte AM, Vergé D, Daval G, Gozlan H, Hamon M (1990) Production of specific anti-rat 5-HT1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci Lett 118:189-192.
19. Engberg G (1989) Nicotine-induced excitation of locus coeruleus neurons is mediated via release of excitatory amino acids. Life Sci 44:1535-1540.
20. Engberg G, Erhardt S, Sharp T, Hajós M (2000) Nicotine inhibits firing activity of dorsal raphe 5-HT neurones in vivo. Naunyn Schmiedebergs Arch Pharmacol 362:41-45.
21. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736.
22. Gorea E, Adrien J (1988) Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors. Eur J Pharmacol 154:285-291.
23. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25:8593-8600.
24. 1A receptor mutant mice. Proc Natl Acad Sci U S A 95:15049-15054.
25. Itzhak Y, Martin JL (1999) Effects of cocaine, nicotine, dizocipline and alcohol on mice locomotor activity: cocaine-alcohol cross-sensitization involves upregulation of striatal dopamine transporter binding sites. Brain Res 818:204-211.
26. Itzhak Y, Achat-Mendes CN, Ali SF, Anderson KL (2004) Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice. Neuropharmacology 46:74-84.
27. Kalivas PW, Duffy P (1998) Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J Neurochem 70:1497-1502.
28. Kita T, Nakashima T, Shirase M, Asahina M, Kurogochi Y (1988) Effects of nicotine on ambulatory activity in mice. Jpn J Pharmacol 46:141-146.
29. Kelly PH, Iversen SD (1976) Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40:45-56.
30. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522.
31. 3H]acetylcholine to nicotinic receptors. Neuropharmacology 24:527-531.
32. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
33. Lanteri C, Salomon L, Torrens Y, Glowinski J, Tassin JP (2008) Drugs of abuse specifically sensitize noradrenergic and serotonergic neurons via a non dopaminergic mechanism. Neuropsychopharmacology 33:1724-1734.
34. Legrand C, Maltier JP, Benghan-Eyene Y (1987) Rat myometrial adrenergic receptors in late pregnancy. Biol Reprod 37:641-650.
35. Lewis A, Miller JH, Lea RA (2007) Monoamine oxidase and tobacco dependence. Neurotoxicology 28:182-195.
36. Li X, Rainnie DG, McCarley RW, Greene RW (1998) Presynaptic nicotinic receptors facilitate monoaminergic transmission. J Neurosci 18:1904-1912.
37. Marks MJ, Burch JB, Collins AC (1983) Genetics of nicotine response in four inbred strains of mice. J Pharmacol Exp Ther 226:291-302.
38. Medioni J, Berlin I, Mallet A (2005) Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach. Addiction 100:247-254.
39. Mhaouty-Kodja S, Houdeau E, Cohen-Tannoudji J, Legrand C (2001) Catecholamines are not linked to myometrial phospholipase C and uterine contraction in late pregnant and parturient mouse. J Physiol 536:123-131.
40. Mihailescu S, Palomero-Rivero M, Meade-Huerta P, Maza-Flores A, Drucker-Colín R (1998) Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur J Pharmacol 360:31-36.
41. Millan MJ, Gobert A, Lejeune F, Newman-Tancredi A, Rivet JM, Auclair A, Peglion JL (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. J Pharmacol Exp Ther 298:565-580.
42. Mitchell SN (1993) Role of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacology 32:937-949.
43. Nestler EJ (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439-2450.
44. Nisell M, Nomikos GG, Svensson TH (1994) Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75:348-352.
45. Paxinos G, Franklin KBJ (1997) The mouse brain in stereotaxic coordinates, Ed 2. New York: Academic.
46. Pierce RC, Kalivas PW (1997) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254-3261.
47. Pierce RC, Bell K, Duffy P, Kalivas PW (1996) Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560.
48. Poindexter E, Carpenter R (1962) The isolation of harmane and norharmane from tobacco and cigarette smoke. Phytochemistry 1:215-221.
49. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
50. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD (1995) Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 15:1261-1274.
51. Riad M, Watkins KC, Doucet E, Hamon M, Descarries L (2001) Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci 21:8378-8386.
52. 18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci 24:5420-5426.
53. Rommelspacher H, Meier-Henco M, Smolka M, Kloft C (2002) The levels of norharman are high enough after smoking to affect monoamine oxidase B in platelets. Eur J Pharmacol 441:115-125.
54. Salomon L, Lanteri C, Glowinski J, Tassin JP (2006) Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci U S A 103:7476-7481.
55. Silagy C, Lancaster T, Stead L, Mant D, Fowler G (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004:CD000146.
56. Smolen A, Marks MJ, DeFries JC, Henderson ND (1994) Individual differences in sensitivity to nicotine in mice: response to six generations of selective breeding. Pharmacol Biochem Behav 49:531-540.
57. Szabo ST, Blier P (2001) Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 922:9-20.
58. Tassin JP (2008) Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. Biochem Pharmacol 75:85-97.
59. Vezina P (1996) D1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 16:2411-2420.
60. Vezina P, Blanc G, Glowinski J, Tassin JP (1992) Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J Pharmacol Exp Ther 261:484-490.
61. Villégier AS, Blanc G, Glowinski J, Tassin JP (2003) Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors. Pharmacol Biochem Behav 76:267-274.
62. Villégier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, Leslie FM, Tassin JP (2006a) Monoamine oxidases inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31:1704-1713.
63. Villégier AS, Salomon L, Blanc G, Godeheu G, Glowinski J, Tassin JP (2006b) Irreversible blockade of monoamine oxidases reveals the critical role of 5-HT transmission in locomotor response induced by nicotine in mice. Eur J Neurosci 24:1359-1365.